4.7 Article

Vkorc1 variation in house mice during warfarin and difenacoum field trials

期刊

PEST MANAGEMENT SCIENCE
卷 69, 期 3, 页码 409-413

出版社

JOHN WILEY & SONS LTD
DOI: 10.1002/ps.3306

关键词

house mouse; Mus musculus domesticus; resistance to anticoagulants; rodenticide treatment; rodent control; Vkorc1; warfarin; difenacoum

资金

  1. Syngenta
  2. Rentokil
  3. Pelgar
  4. Liphatech
  5. BASF
  6. Bayer CropScience
  7. National Institute of Health [R01-HL091007-01A1]

向作者/读者索取更多资源

BACKGROUND: Field studies guided by genetic monitoring of Vkorc1 need to be done to implicate mutations conclusively with rodent control problems due to the presence of animals resistant to anticoagulant rodenticides. Rodent control success in relation to Vkorc1 genotypes in house mice (Mus musculus domesticus) was studied on two farms (I and II) in Germany. Tests were carried out to determine whether certain resistance profiles and Vkorc1 genotypes displayed dynamics over the course of sequential treatments with warfarin and difenacoum that were consistent with single nucleotide polymorphisms (SNPs) in Vkorc1 as indicators of resistance. RESULTS: On farms I and II, respectively, three (A to C) and two (A and B) types of control problem with anticoagulants (i.e. proxies for resistance) were encountered in spatially segregated subunits: A = none; B = control problems with warfarin but not with difenacoum; C = control problems with both anticoagulants. Unexpectedly, resistance was encountered in a population where only Vkorc1 wild-type mice were detected. In addition, the Arg58Gly Vkorc1 variant was found not to correlate with observed control failures. CONCLUSION: Control problems were encountered that cannot be explained by Vkorc1 coding or intronic SNPs, and therefore are likely due to non-coding Vkorc1 SNPs or due to other genetic or non-genetic factors. (c) 2012 Society of Chemical Industry

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据